• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Researchers views about perceived harms and benefits of gene editing: A study from the MENA region.研究人员对基因编辑的感知危害和益处的看法:一项来自中东和北非地区的研究。
Heliyon. 2021 Apr 23;7(4):e06860. doi: 10.1016/j.heliyon.2021.e06860. eCollection 2021 Apr.
2
Challenges Faced by Behavioral Genetic Studies: Researchers Perspective from the MENA Region.行为遗传学研究面临的挑战:中东和北非地区研究者的视角
Curr Genomics. 2021 Dec 31;22(7):550-556. doi: 10.2174/1389202923666211216162141.
3
Challenges that face the establishment of diabetes biobank in Jordan: a qualitative analysis of an online discussion forum.约旦建立糖尿病生物样本库面临的挑战:在线讨论论坛的定性分析
J Multidiscip Healthc. 2019 Mar 29;12:229-234. doi: 10.2147/JMDH.S194161. eCollection 2019.
4
Awareness and perception of pharmacy researchers about conflict of interest: A study from the MENA region.中东和北非地区药学研究人员对利益冲突的认识与认知:一项研究
J Appl Pharm Sci. 2022 Aug;12(8):148-155. doi: 10.7324/japs.2022.120815. Epub 2022 Aug 4.
5
The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.中东和北非(MENA)地区非传染性疾病(NCD)研究概况:分析 NCD 负担、研究成果和国际研究合作。
PLoS One. 2020 Apr 27;15(4):e0232077. doi: 10.1371/journal.pone.0232077. eCollection 2020.
6
Ethical, Legal, and Sociocultural Issues in the Use of Mobile Technologies and Call Detail Records Data for Public Health in the East African Region: Scoping Review.东非地区将移动技术和通话记录数据用于公共卫生的伦理、法律及社会文化问题:范围综述
Interact J Med Res. 2022 Jun 2;11(1):e35062. doi: 10.2196/35062.
7
Ethical and legal implications of gene editing in plant breeding: a systematic literature review.植物育种中基因编辑的伦理和法律影响:系统文献综述。
J Zhejiang Univ Sci B. 2023 Jul 10;24(12):1093-1105. doi: 10.1631/jzus.B2200601.
8
Assessing the capacity for conflict and health research in Lebanon: a qualitative study.评估黎巴嫩冲突与健康研究的能力:一项定性研究。
Confl Health. 2020 Aug 18;14:59. doi: 10.1186/s13031-020-00304-x. eCollection 2020.
9
The Impact of COVID-19 on Drug Use and Harm Reduction Programming in the Middle East and North Africa (MENA) Region: a Regional Consultation of Stakeholders and People Who Use Drugs.2019冠状病毒病对中东和北非地区药物使用及减少伤害规划的影响:利益相关者和吸毒者区域磋商会
Int J Ment Health Addict. 2022;20(4):2072-2085. doi: 10.1007/s11469-021-00500-7. Epub 2021 Jul 13.
10
-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool.Δ32生物学、基因编辑以及对CRISPR-Cas9作为一种人类和人道基因编辑工具的未来警示。
Cell Biosci. 2020 Mar 30;10:48. doi: 10.1186/s13578-020-00410-6. eCollection 2020.

引用本文的文献

1
Human Heritable Genome Editing and its Governance: Views of Scientists and Governance Professionals.人类可遗传基因组编辑及其治理:科学家和治理专业人士的观点
New Genet Soc. 2024;43(1). doi: 10.1080/14636778.2024.2404061. Epub 2024 Sep 20.
2
Ethical Aspects of Human Genome Research in Sports-A Narrative Review.体育人类基因组研究的伦理问题——叙事性综述。
Genes (Basel). 2024 Sep 18;15(9):1216. doi: 10.3390/genes15091216.
3
The role of zygotic genome activation in genetic-related reproductive medicine: Technological perspective, religious and bioethical concerns, challenges and benefits.合子基因组激活在遗传相关生殖医学中的作用:技术视角、宗教和生物伦理问题、挑战与益处。
J Genet Eng Biotechnol. 2024 Mar;22(1):100340. doi: 10.1016/j.jgeb.2023.100340. Epub 2024 Jan 23.
4
Ethical Perspectives of Therapeutic Human Genome Editing From Multiple and Diverse Viewpoints: A Scoping Review.从多个不同视角看治疗性人类基因组编辑的伦理观点:一项范围综述
Cureus. 2022 Nov 27;14(11):e31927. doi: 10.7759/cureus.31927. eCollection 2022 Nov.

本文引用的文献

1
CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases.CRISPR/Cas9 新型治疗方法治疗神经退行性疾病。
Life Sci. 2020 Oct 15;259:118165. doi: 10.1016/j.lfs.2020.118165. Epub 2020 Jul 29.
2
CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy.CRISPR/Cas 系统克服了开发下一代用于癌症治疗的 T 细胞的挑战。
Adv Drug Deliv Rev. 2020;158:17-35. doi: 10.1016/j.addr.2020.07.015. Epub 2020 Jul 21.
3
Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies.CRISPR/Cas9基因编辑在淋巴恶性肿瘤细胞治疗中的应用。
Immunol Lett. 2020 Oct;226:71-82. doi: 10.1016/j.imlet.2020.07.003. Epub 2020 Jul 17.
4
Next-generation stem cells - ushering in a new era of cell-based therapies.下一代干细胞——开创细胞治疗新时代。
Nat Rev Drug Discov. 2020 Jul;19(7):463-479. doi: 10.1038/s41573-020-0064-x. Epub 2020 Apr 6.
5
The delivery challenge: fulfilling the promise of therapeutic genome editing.递送挑战:实现治疗性基因组编辑的承诺。
Nat Biotechnol. 2020 Jul;38(7):845-855. doi: 10.1038/s41587-020-0565-5. Epub 2020 Jun 29.
6
Ethical issues related to research on genome editing in human embryos.与人类胚胎基因编辑研究相关的伦理问题。
Comput Struct Biotechnol J. 2020 Mar 21;18:887-896. doi: 10.1016/j.csbj.2020.03.014. eCollection 2020.
7
Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective.CRISPR-Cas 系统基因组编辑:艺术、伦理和全球监管视角。
Plant Biotechnol J. 2020 Aug;18(8):1651-1669. doi: 10.1111/pbi.13383. Epub 2020 Apr 30.
8
The promise and challenge of therapeutic genome editing.治疗性基因组编辑的前景与挑战。
Nature. 2020 Feb;578(7794):229-236. doi: 10.1038/s41586-020-1978-5. Epub 2020 Feb 12.
9
Yesterday's Child: How Gene Editing for Enhancement Will Produce Obsolescence-and Why It Matters.昨日之子:基因编辑增强如何导致淘汰——以及为何这很重要。
Am J Bioeth. 2019 Jul;19(7):6-15. doi: 10.1080/15265161.2019.1618943.
10
Germ-Inating Solutions or Gene-Rating Problems: An Islamic Perspective on Human Germline Gene Editing.发芽的解决方案还是基因的问题:从伊斯兰教视角看人类生殖系基因编辑。
J Relig Health. 2020 Aug;59(4):1855-1869. doi: 10.1007/s10943-019-00770-5.

研究人员对基因编辑的感知危害和益处的看法:一项来自中东和北非地区的研究。

Researchers views about perceived harms and benefits of gene editing: A study from the MENA region.

作者信息

Abuhammad Sawsan, Khabour Omar F, Alzoubi Karem H

机构信息

Dept. of Maternal and Child Health, Jordan University of Science and Technology, Irbid 22110, Jordan.

Dept. of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.

出版信息

Heliyon. 2021 Apr 23;7(4):e06860. doi: 10.1016/j.heliyon.2021.e06860. eCollection 2021 Apr.

DOI:10.1016/j.heliyon.2021.e06860
PMID:33997394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8095113/
Abstract

BACKGROUND

The development of gene editing technologies is very promising for the treatment of genetic diseases. However, gene editing can be also used to enhance the characteristics of healthy individuals. This study aims to determine ethical challenges that may face the constitution of gene editing in the Middle East and North Africa (MENA) region.

METHODS

An online discussion forum about the ethical challenges of applying gene editing technologies was held. The participants were a group of researchers (n = 28) from the MENA region.

RESULTS

Most of the participants agreed on the importance of gene editing for the treatment of genetic diseases. However, participants had concerns regarding the use of gene editing to enhance the characteristics of healthy individuals such as athletic abilities and intelligence. Among ethical issues that were raised are justice, harm, beneficence, discrimination, conflict with religion and culture, and lack of regulations.

CONCLUSION

Several ethical issues were raised for using gene editing technologies based on the perception of biomedical researchers from the MENA region. Therefore, the scientific community and other interested bioethical, social, legal, and governmental parties should be provided with a detailed guide from the scientists in this area for future uses of this technology.

摘要

背景

基因编辑技术的发展在治疗遗传疾病方面前景广阔。然而,基因编辑也可用于增强健康个体的特征。本研究旨在确定中东和北非(MENA)地区在基因编辑构成方面可能面临的伦理挑战。

方法

举办了一个关于应用基因编辑技术的伦理挑战的在线讨论论坛。参与者是来自MENA地区的一组研究人员(n = 28)。

结果

大多数参与者认同基因编辑在治疗遗传疾病方面的重要性。然而,参与者对利用基因编辑来增强健康个体的特征,如运动能力和智力表示担忧。所提出的伦理问题包括正义、伤害、行善、歧视、与宗教和文化的冲突以及缺乏监管。

结论

基于MENA地区生物医学研究人员的认知,使用基因编辑技术引发了若干伦理问题。因此,科学界以及其他感兴趣的生物伦理、社会、法律和政府各方应获得该领域科学家提供的详细指南,以便未来使用这项技术。